Edition:
United States

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

6.26USD
1:46pm EST
Change (% chg)

$0.08 (+1.29%)
Prev Close
$6.18
Open
$6.17
Day's High
$6.33
Day's Low
$6.09
Volume
78,069
Avg. Vol
126,407
52-wk High
$14.62
52-wk Low
$5.73

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.33 December 12 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 2 2
(2) OUTPERFORM 3 4 4 4
(3) HOLD 2 1 1 1
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.11 2.00 2.12 2.12

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 8 5.72 20.00 0.00 3.73
Quarter Ending Mar-19 4 3.50 7.00 0.00 --
Year Ending Dec-18 8 62.07 78.00 50.00 52.40
Year Ending Dec-19 8 24.75 65.00 0.00 16.42
Earnings (per share)
Quarter Ending Dec-18 6 -0.33 -0.23 -0.50 -0.30
Quarter Ending Mar-19 3 -0.32 -0.26 -0.36 --
Year Ending Dec-18 6 -0.96 -0.87 -1.11 -0.81
Year Ending Dec-19 6 -1.18 -0.94 -1.45 -1.46

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 33.03 40.79 7.76 23.51
Quarter Ending Jun-18 8.71 9.04 0.33 3.77
Quarter Ending Mar-18 9.10 8.20 0.91 9.96
Quarter Ending Dec-17 8.56 4.27 4.29 50.10
Quarter Ending Sep-17 6.26 27.18 20.93 334.54
Earnings (per share)
Quarter Ending Sep-18 -0.05 0.06 0.12 -209.09
Quarter Ending Jun-18 -0.27 -0.48 0.21 -75.63
Quarter Ending Mar-18 -0.24 -0.22 0.02 -8.98
Quarter Ending Dec-17 -0.23 -0.30 0.07 -31.41
Quarter Ending Sep-17 -0.23 -0.01 0.22 -96.03

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5.72 6.22 6.22 6.68 3.73
Quarter Ending Mar-19 3.50 3.50 3.50 2.00 --
Year Ending Dec-18 62.07 56.41 56.41 55.87 52.40
Year Ending Dec-19 24.75 24.75 24.75 26.57 16.42
Earnings (per share)
Quarter Ending Dec-18 -0.33 -0.34 -0.35 -0.35 -0.30
Quarter Ending Mar-19 -0.32 -0.32 -0.33 -0.34 --
Year Ending Dec-18 -0.96 -1.00 -1.01 -1.01 -0.81
Year Ending Dec-19 -1.18 -1.23 -1.24 -1.24 -1.46

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 1 0 1
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 6 1 6 1
Year Ending Dec-19 0 0 0 0
Earnings
Quarter Ending Dec-18 3 0 4 0
Quarter Ending Mar-19 1 1 2 1
Year Ending Dec-18 3 1 3 1
Year Ending Dec-19 4 1 4 1